Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, we have concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of our technologies are applicable to the biomedical and pharmaceutical research markets, and we are further using these technologies as a platform for our entry into the clinical diagnostics market. Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, Enzo's work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. In the course of our extensive research and development activities, we have built a significant patent position consisting of numerous pioneer patents and applications that encompass our core technologies. The business activities of Enzo Biochem are performed by the company's three wholly owned subsidiaries - Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include: (1) research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences, (2) research and development of therapeutic products through Enzo Therapeutics and (3) the operation of a regional clinical reference laboratory through Enzo Clinical Labs.